CliffBio
small molecule

SEVELAMER CARBONATE

SEVELAMER CARBONATE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameSEVELAMER CARBONATE
Active ingredientSEVELAMER CARBONATE
Strength2.4GM/PACKET
Dosage formFOR SUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2021
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.